Syncona Ltd - Company Profile
Powered by
All the data and insights you need on Syncona Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Syncona Ltd Strategy Report
- Understand Syncona Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Syncona Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
18 Jul 2022 | SwanBio Therapeutics Enters into Licensing Agreement with Purespring Therapeutics | Licensing Agreement |
SwanBio Therapeutics Limited
|
Purespring Therapeutics Ltd
|
18 May 2022 | SwanBio Therapeutics Raises USD56 Million in Series B Financing | Venture Financing |
Syncona Ltd
Mass General Brigham Ventures
|
SwanBio Therapeutics Ltd
|
27 Apr 2022 | Quell Therapeutics and Cellistic Enter into Co-Development Agreement | Partnership | - |
Quell Therapeutics Ltd
Cellistic
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward